*ST仁東(002647.SZ):《支付業務許可證》處於中止續展審查階段
格隆匯7月4日丨*ST仁東(002647.SZ)公佈,公司控股孫公司廣州合利寶支付科技有限公司(以下簡稱“合利寶”)《支付業務許可證》於2019年7月9日續展,有效期至2024年7月9日。根據《非銀行支付機構監督管理條例實施細則》等相關規定,有效期過渡至2025年7月9日。
2025年7月4日,中國人民銀行在其官方網站公佈了《非銀行支付機構<支付業務許可證>續展(換證)公示信息(2025年7月第一批次)》。因合利寶申請續展時,其間接控股股東仁東控股進入重整程序,根據《中國人民銀行行政許可實施辦法》第二十四條規定,中國人民銀行決定對合利寶中止審查。中止審查階段,合利寶各項業務均正常開展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.